Association of variation in Fcγ receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples

Annals of the Rheumatic Diseases

Volumn 69, Issue 9, 2010, Pages 1711-1716

  McKinney, Cushla ^a   Fanciulli, Manuela ^b   Merriman, Marilyn E ^a   Phipps Green, Amanda ^a   Alizadeh, Behrooz Z ^c   Koeleman, Bobby P C ^c   Dalbeth, Nicola ^d   Gow, Peter J ^e   Harrison, Andrew A ^a   Highton, John ^a   Jones, Peter B ^d   Stamp, Lisa K ^f   Steer, Sophia ^g   Barrera, Pilar ^h   Coenen, Marieke J H ^h   Franke, Barbara ^h   Van Riel, Piet L C M ^h   Vyse, Tim J ^b   Aitman, Tim J ^b   Radstake, Timothy R D J ^h   Merriman, Tony R ^a   more..

^a UNIVERSITY OF OTAGO   (New Zealand)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e MIDDLEMORE HOSPITAL   (New Zealand)

^f UNIVERSITY OF OTAGO   (New Zealand)

^g KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; FC GAMMA RECEPTOR 3B; UNCLASSIFIED DRUG; FC RECEPTOR; FCGR3B PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE DOSAGE; GENE FREQUENCY; GENE LOCATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NEUTROPHIL; NEW ZEALAND; PHENOTYPE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; UNITED KINGDOM; ADOLESCENT; CASE CONTROL STUDY; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MIDDLE AGED; MULTICENTER STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, IGG; YOUNG ADULT;

EID: 77956053958     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.123588     Document Type: Article

References (49)

1. McKinney C, Merriman ME, Chapman PT, et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis 2008;67:409-13. (Pubitemid 351281279)
2. Mamtani M, Rovin B, Brey R, et al. CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis 2008;67:1076-83.
3. Bentley RW, Pearson J, Gearry RB, et al. Association of higher DEFB4 genomic copy number with Crohn's disease. Am J Gastroenterol 2010;105:354-9.
4. Hollox EJ, Huffmeier U, Zeeuwen PL, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 2008;40:23-5.
5. Aitman TJ, Dong R, Vyse TJ, et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006;439:851-5.
6. Fanciulli M, Norsworthy PJ, Petretto E, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 2007;39:721-3.
7. Willcocks LC, Lyons PA, Clatworthy MR, et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med 2008;205:1573-82.
8. Fanger MW, Shen L, Graziano RF, et al. Cytotoxicity mediated by human Fc receptors for IgG. Immunol Today 1989;10:92-9. (Pubitemid 19087465)
9. Kocher M, Siegel ME, Edberg JC, et al. Cross-linking of Fc gamma receptor IIa and Fc gamma receptor IIIb induces different proadhesive phenotypes on human neutrophils. J Immunol 1997;159:3940-8.
10. Coxon A, Cullere X, Knight S, et al. Fc gamma RIII mediates neutrophil recruitment to immune complexes. A mechanism for neutrophil accumulation in immune-mediated inflammation. Immunity 2001;14:693-704.
11. Fossati G, Moots RJ, Bucknall RC, et al. Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. Arthritis Rheum 2002;46:1351-61. (Pubitemid 34525845)
12. Durand V, Pers JO, Renaudineau Y, et al. Soluble Fcgamma receptor IIIb alters the function of polymorphonuclear neutrophils but extends their survival. Eur J Immunol 2001;31:1952-61.
13. Youinou P, Durand V, Renaudineau Y, et al. Pathogenic effects of anti-Fc gamma receptor IIIb (CD16) on polymorphonuclear neutrophils in non-organ-specific autoimmune diseases. Autoimmun Rev 2002;1:13-19.
14. Peng SL. Neutrophil apoptosis in autoimmunity. J Mol Med 2006;84:122-5.
15. Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol 2001;167:1601-8.
16. Mandik-Nayak L, Allen PM. Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis. Immunol Res 2005;32:5-13. (Pubitemid 41153610)
17. Edwards SW, Hallett MB. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today 1997;18:320-4.
18. Lee YH, Ji JD, Song GG. Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a metaanalysis. J Rheumatol 2008;35:2129-35.
19. Fairhurst AM, Wallace PK, Jawad AS, et al. Rheumatoid peripheral blood phagocytes are primed for activation but have impaired Fc-mediated generation of reactive oxygen species. Arthritis Res Ther 2007;9:R29.
20. Morgan AW, Barrett JH, Griffiths B, et al. Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis Res Ther 2006;8:R5.
21. Hollox EJ, Detering JC, Dehnugara T. An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus. Hum Mutat 2009;30:477-84.
22. Welsing PM, van Riel PL. The Nijmegen inception cohort of early rheumatoid arthritis. J Rheumatol Suppl 2004;69:14-21.
23. Kievit W, Fransen J, Oerlemans AJ, et al. The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice. Ann Rheum Dis 2007;66:1473-8.
24. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Breunis WB, van Mirre E, Geissler J, et al. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Hum Mutat 2009;30:E640-50.
26. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005;307:1434-40.
27. Cukier HN, Pericak-Vance MA, Gilbert JR, et al. Sample degradation leads to false-positive copy number variation calls in multiplex real-time polymerase chain reaction assays. Anal Biochem 2009;386:288-90.
28. Barnes C, Plagnol V, Fitzgerald T, et al. A robust statistical method for case-control association testing with copy number variation. Nat Genet 2008;40:1245-52.
29. Armour JA, Palla R, Zeeuwen PL, et al. Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats. Nucleic Acids Res 2007;35:e19.
30. Wordsworth BP, Lanchbury JS, Sakkas LI, et al. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci USA 1989;86:10049-53.
31. Lee YH, Rho YH, Choi SJ, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases - a meta-analysis. Rheumatology (Oxford) 2007;46:49-56.
32. Plenge RM, Cotsapas C, Davies L, et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007;39:1477-82.
33. Thomson W, Barton A, Ke X, et al. Rheumatoid arthritis association at 6q23. Nat Genet 2007;39:1431-3.
34. Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007;357:977-86.
35. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 2007;357:1199-209.
36. Kurreeman FA, Rocha D, Houwing-Duistermaat J, et al. Replication of the tumor necrosis factor receptor-associated factor 1/complement component 5 region as a susceptibility locus for rheumatoid arthritis in a European family-based study. Arthritis Rheum 2008;58:2670-4.
37. Barton A, Thomson W, Ke X, et al. Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nat Genet 2008;40:1156-9.
38. Raychaudhuri S, Remmers EF, Lee AT, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008;40:1216-23.
39. Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146:797-808.
40. Tsuboi N, Asano K, Lauterbach M, et al. Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity 2008;28:833-46.
41. Tsuchiya N, Kyogoku C, Miyashita R, et al. Diversity of human immune system multigene families and its implication in the genetic background of rheumatic diseases. Curr Med Chem 2007;14:431-9. (Pubitemid 46299689)
42. de Haas M, Kleijer M, van Zwieten R, et al. Neutrophil Fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 1995;86:2403-13.
43. Cassel DL, Keller MA, Surrey S, et al. Differential expression of Fc gamma RIIA, Fc gamma RIIB and Fc gamma RIIC in hematopoietic cells: analysis of transcripts. Mol Immunol 1993;30:451-60. (Pubitemid 223038396)
44. Metes D, Galatiuc C, Moldovan I, et al. Expression and function of Fc gamma RII on human natural killer cells. Nat Immun 1994;13:289-300.
45. Ernst LK, Metes D, Herberman RB, et al. Allelic polymorphisms in the FcgammaRIIC gene can influence its function on normal human natural killer cells. J Mol Med 2002;80:248-57.
46. Pazmany L. Do NK cells regulate human autoimmunity? Cytokine 2005;32:76-80. (Pubitemid 41563036)
47. Dalbeth N, Callan MF. A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum 2002;46:1763-72.
48. Villanueva J, Lee S, Giannini EH, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005;7:R30-7.
49. Stewart-Akers AM, Cunningham A, Wasko MC, et al. Fc gamma R expression on NK cells influences disease severity in rheumatoid arthritis. Genes Immun 2004;5:521-9.